PLoS ONE (Jan 2019)

The GCN2 inhibitor IMPACT contributes to diet-induced obesity and body temperature control.

  • Catia M Pereira,
  • Renato Filev,
  • Francisco P Dubiela,
  • Bruna B Brandão,
  • Claudio M Queiroz,
  • Raissa G Ludwig,
  • Debora Hipolide,
  • Beatriz M Longo,
  • Luiz E Mello,
  • Marcelo A Mori,
  • Beatriz A Castilho

DOI
https://doi.org/10.1371/journal.pone.0217287
Journal volume & issue
Vol. 14, no. 6
p. e0217287

Abstract

Read online

IMPACT, a highly conserved protein, is an inhibitor of the eIF2α kinase GCN2. In mammals, it is preferentially expressed in neurons. Knock-down of IMPACT expression in neuronal cells increases basal GCN2 activation and eIF2α phosphorylation and decreases translation initiation. In the mouse brain, IMPACT is particularly abundant in the hypothalamus. Here we describe that the lack of IMPACT in mice affects hypothalamic functions. Impact-/- mice (Imp-KO) are viable and have no apparent major phenotypic defect. The hypothalamus in these animals shows increased levels of eIF2α phosphorylation, as expected from the described role of IMPACT in inhibiting GCN2 and from its abundance in this brain region. When fed a normal chow, animals lacking IMPACT weight slightly less than wild-type mice. When fed a high-fat diet, Imp-KO animals gain substantially less weight due to lower food intake when compared to wild-type mice. STAT3 signaling was depressed in Imp-KO animals even though leptin levels were identical to the wild-type mice. This finding supports the observation that Imp-KO mice have defective thermoregulation upon fasting. This phenotype was partially dependent on GCN2, whereas the lean phenotype was independent of GCN2. Taken together, our results indicate that IMPACT contributes to GCN2-dependent and -independent mechanisms involved in the regulation of autonomic functions in response to energy availability.